Too much or too little? The trajectory of systemic anti-cancer treatment throughout the last year of life of lung cancer patients in Norway

Abstract Background The use of systemic anti-cancer treatment (SACT) at the end of life (EOL) is controversial. The evidence and detailed description of the dynamics of its use are deficient, especially after the introduction of targeted therapies and immunotherapy. Methods Clinical information abou...

Full description

Bibliographic Details

Published in:	BJC Reports
Main Authors:	Steinar Solberg, Kathinka Schmidt Slørdahl, Marianne Aanerud, Odd Terje Brustugun, Bjørn Henning Grønberg, Nina Helbekkmo, Åslaug Helland, Yngvar Nilssen
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-10-01
Online Access:	https://doi.org/10.1038/s44276-025-00183-w